MEROSIN-DEFICIENT CONGENITAL MUSCULAR DYSTROPHY (CMD1A): CLINICAL CASE OF CONGENITAL MUSCULAR DYSTROPHY INVOLVING CENTRAL NERVOUS SYSTEM

Congenital muscular dystrophies (CMDs) are an extremely heterogenous group of neuromuscular diseases. The article presents the general information on clinical and pathogenetic aspects of CMD diagnosis with emphasis on one of the most common forms of nervous system disturbances — merosin-deficient congenital muscular dystrophy (CMD1A). The authors describe clinical pattern of CMD1A, pathogenesis, epidemiological data, approaches to instrumental, morphological and molecular genetic diagnosis, as well as symptomatic treatment and prenatal diagnosis in detail. As long as there are few genetically confirmed clinical cases of CMD1A described in the publications written in Russian, the authors present their 3-year-long follow-up of a child with genetically confirmed diagnosis of CMD1A (mutations c.2049_2050delAG and c.6993-2A > C of gene LAMA2 [compound heterozygous state]). The article presents a detailed discussion of the described case, comparison with results of recent foreign and Russian observational studies of CMD1A in children. It also contains information on differential diagnosis of CMD1A in the structure of other congenital myodystrophies and optimization of molecular genetic diagnosis.

1. Rivier F., Meyer P., Walther-Louvie U., Mercier M., Echenne B., Quijano-Roy S. Congenital muscular dystrophy: Classification and diagnosis. Nervno-myshechnye bolezni – Neuromuscular diseases. 2014; 1: 6−20.

2. Tomé F.M., Evangelista T., Leclerc A., Sunada Y., Manole E., Estournet B., Barois A., Campbell K.P., Fardeau M. Congenital muscular dystrophy with merosin deficiency. C R Acad Sci III. 1994; 317 (4): 351−7.

3. Hillaire D., Leclerc A., Fauré S., Topaloglu H., Chiannilkulchaï N., Guicheney P., Grinas L., Legos P., Philpot J., Evangelista T. Localization of merosin-negative congenital muscular dystrophy to chromosome 6q2 by homozygosity mapping. Hum Mol Genet. 1994; 3 (9): 1657−61.

4. Clement E.M., Feng L., Mein R., Sewry C.A., Robb S.A., Manzur A.Y., Mercuri E., Godfrey C., Cullup T., Abbs S., Muntoni F. Relative frequency of congenital muscular dystrophy subtypes: analysis of the UK diagnostic service 2001−2008. Neuromuscul Disord. 2012; 22 (6): 522−7.

5. Darin N., Tulinius M. Neuromuscular disorders in childhood: a descriptive epidemiological study from western Sweden. Neuromuscul Disord. 2000; 10 (1): 1−9.

6. Norwood F.L., Harling C., Chinnery P.F., Eagle M., Bushby K., Straub V. Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population. Brain. 2009; 132 (Pt. 11): 3175−86.

7. Peat R.A., Smith J.M., Compton A.G., Baker N.L., Pace R.A., Burkin D.J., Kaufman S.J., Lamandé S.R., North K.N. Diagnosis and etiology of congenital muscular dystrophy. Neurology. 2008; 71 (5): 312−21.

8. Aver'yanov Yu.N. Vrozhdennaya myshechnaya distrofiya s leikoentsefalopatiei. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova – S.S. Korsakov journal of neurology and psychiatry. 1993; 5: 27−29.

9. Rudenskaya G.E., Galkina V.A., Dunaevskaya G.N. Rare forms of hereditary progressive muscular dystrophy with contractures. Teoreticheskie i prikladnye problemy med. genetiki – Theoretical and applied problems of medical genetics. 1993; 7: 105−119.

10. Rudenskaya G.E., Dadali E.L., Sitnikov V.F. Hereditary concomitant tserebromyshechnaya pathology in childhood. Organizatsionnye i klinicheskie problemy detskoi nevrologii i psikhiatrii – Organizational and clinical problems of pediatric neurology and psychiatry. 1993. P. 253−255.

11. Dadali E.L., Rudenskaya G.E., Shchagina O.A., Tiburkova T.B., Sukhorukov V.S., Kharlamov D.A., Polyakov A.V. Merosin-deficient congenital muscular dystrophy (VMD1A). Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova – S.S. Korsakov journal of neurology and psychiatry. 2010; 110 (3): 83−89.

12. Komarova N.V., Tiburkova T.B., Shchagina O.A., Dadali E.L., Rudenskaya G.E., Polyakov A.V. Vrozhdennaya myshechnaya distrofiya, merozin-negativnaya (VMD1A) u rossiiskikh bol'nykh. Materialy VI s"ezda Rossiiskogo obshchestva meditsinskikh genetikov [Congenital muscular dystrophy, merosin-negative (VMD1A) in Russian patients. Proceedings of the VI Congress of the Russian Society of Medical Genetics]. Meditsinskaya genetika (pril. k № 5) – Medical Genetics (app. to issue 5). 2010. 88 p.

13. Mendell J.R., Boué D.R., Martin P.T. The congenital muscular dystrophies: recent advances and molecular insights. Pediatr Dev Pathol. 2006; 9 (6): 427−43.

14. Zhang X., Vuolteenaho R., Tryggvason K. Structure of the human laminin alpha2-chain gene (LAMA2), which is affected in congenital muscular dystrophy. J Biol Chem. 1996; 271 (44): 27664−9.

15. Gawlik K.I., Durbeej M. Skeletal muscle laminin and MDC1A: pathogenesis and treatment strategies. Skelet Muscle. 2011; 1 (1): 9.

16. Geranmayeh F., Clement E., Feng L.H., Sewry C., Pagan J., Mein R., Abbs S., Brueton L., Childs A.M., Jungbluth H., De Goede C.G., Lynch B., Lin J.P., Chow G., Sousa Cd, O'Mahony O., Majumdar A., Straub V., Bushby K., Muntoni F. Genotype-phenotype correlation in a large population of muscular dystrophy patients with LAMA2 mutations. Neuromuscul Disord. 2010; 20 (4): 241−50.

17. Philpot J., Bagnall A., King C., Dubowitz V., Muntoni F. Feeding problems in merosin deficient congenital muscular dystrophy. Arch Dis Child. 1999; 80 (6): 542−7.

18. Tezak Z., Prandini P., Boscaro M., Marin A., Devaney J., Marino M., Fanin M., Trevisan C.P., Park J., Tyson W., Finkel R., Garcia C., Angelini C., Hoffman E.P., Pegoraro E. Clinical and molecular study in congenital muscular dystrophy with partial laminin alpha 2 (LAMA2) deficiency. Hum Mutat. 2003; 21 (2): 103−11.

19. Jones K.J., Morgan G., Johnston H., Tobias V., Ouvrier R.A., Wilkinson I., North K.N. The expanding phenotype of laminin alpha2 chain (merosin) abnormalities: case series and review. J Med Genet. 2001; 38 (10): 649−57.

20. Leite C.C., Lucato L.T., Martin M.G., Ferreira L.G., Resende M.B., Carvalho M.S., Marie S.K., Jinkins J.R., Reed U.C. Merosin-deficient congenital muscular dystrophy (CMD): a study of 25 Brazilian patients using MRI. Pediatr Radiol. 2005; 35 (6): 572−9.

21. Philpot J., Pennock J., Cowan F., Sewry C.A., Dubowitz V., Bydder G., Muntoni F. Brain magnetic resonance imaging abnormalities in merosin-positive congenital muscular dystrophy. Eur J Paediatr Neurol. 2000; 4 (3): 109−14.

22. Bönnemann C.G., Wang C.H., Quijano-Roy S., Deconinck N., Bertini E., Ferreiro A., Muntoni F., Sewry C., Béroud C., Mathews K.D., Moore S.A., Bellini J., Rutkowski A., North K.N. Members of International Standard of Care Committee for Congenital Muscular Dystrophies. Diagnostic approach to the congenital muscular dystrophies. Neuromuscul Disord. 2014; 24 (4): 289−311.

23. Oliveira J., Santos R., Soares-Silva I., Jorge P., Vieira E., Oliveira M.E., Moreira A., Coelho T., Ferreira J.C., Fonseca M.J., Barbosa C., Prats J., Aríztegui M.L., Martins M.L., Moreno T., Heinimann K., Barbot C., Pascual-Pascual S.I., Cabral A., Fineza I., Santos M., Bronze-da-Rocha E. LAMA2 gene analysis in a cohort of 26 congenital muscular dystrophy patients. Clin Genet. 2008; 74 (6): 502−12.

24. Vainzof M., Richard P., Herrmann R., Jimenez-Mallebrera C., Talim B., Yamamoto L.U., Ledeuil C., Mein R., Abbs S., Brockington M., Romero N.B., Zatz M., Topaloglu H., Voit T., Sewry C., Muntoni F., Guicheney P., Tomé F.M. Prenatal diagnosis in laminin alpha2 chain (merosin)-deficient congenital muscular dystrophy: a collective experience of five international centers. Neuromuscul Disord. 2005; 15 (9−10): 588−94.

25. Matsumura K., Yamada H., Saito F., Sunada Y., Shimizu T. Peripheral nerve involvement in merosin-deficient congenital muscular dystrophy and dy mouse. Neuromuscul Disord. 1997; 7 (1): 7−12.

26. Vigliano P., Dassi P., Di Blasi C., Mora M., Jarre L. LAMA2 stop-codon mutation: merosin-deficient congenital muscular dystrophy with occipital polymicrogyria, epilepsy and psychomotor regression. Eur J Paediatr Neurol. 2009; 13 (1): 72−6.